25 November 2017
News and Views
Links and Services
Ribavirin exposure after the first dose is predictive of sustained virological response in chronic Hepatitis C, finds the latest issue of Hepatology.
The impact of ribavirin exposure on sustained virological response in patients with chronic Hepa
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors